Bonsib Stephen M, Boils Christie, Gokden Neriman, Grignon David, Gu Xin, Higgins John P T, Leroy Xavier, McKenney Jesse K, Nasr Samih H, Phillips Carrie, Sangoi Ankur R, Wilson Jon, Zhang Ping L
Nephropath, 10810 Executive Center Drive, Suite 100, Little Rock, AR, 72211, United States.
University of Arkansas, 4301 West Markham, Little Rock, AR, 72205, United States.
Pathol Res Pract. 2016 Nov;212(11):972-979. doi: 10.1016/j.prp.2016.04.005. Epub 2016 Apr 30.
Tuberous sclerosis complex (TSC) results from mutation of TSC1 or TSC2 that encode for hamartin and tuberin. It affects the kidneys often in advance of extra-renal stigmata. We studied 14 TSC cases, and 4 possible TSC cases with multiple angiomyolipomas (AMLs) for hamartin and tuberin protein expression to determine if the staining profile could predict mutation status or likelihood of TSC with renal-limited disease. The 18 cases included 15 nephrectomies and 1 section of 6 TSC-associated renal cell carcinomas (RCC). Controls included the non-neoplastic kidney in 5 tumor nephrectomies, 4 sporadic cases of AML and 6 clear cell RCCs. In the 14 TSC cases, 9 had AMLs, 9 had RCCs, 5 had polycystic kidney disease and 8 had eosinophilic cysts (EC) lined by large eosinophilic cells. The controls and study cases showed luminal staining of proximal tubules (PT) and peripheral membrane staining in distal tubules/collecting ducts for hamartin and cytoplasmic staining for tuberin. Eosinophilic cysts had a luminal PT-like stain with hamartin and a cytoplasmic reaction for tuberin. Hamartin stained myoid cells in all AMLs. Tuberin was negative in all but 1AML, an epithelioid AML. All but 1 RCC were positive for tuberin; 13 RCCs (7 TSC/6 non-TSC) were negative for hamartin and 4 showed a weak reaction. We conclude that the ECs of TSC are proximal tubule-derived. The hamartin and tuberin staining profiles of AMLs and most RCCs are reciprocal precluding prediction of the mutation in TSC, and fail to predict if a patient with multifocal AML has TSC.
结节性硬化症(TSC)由编码错构瘤蛋白和结节蛋白的TSC1或TSC2突变引起。它通常在出现肾外体征之前就影响肾脏。我们研究了14例TSC病例以及4例可能患有多发血管平滑肌脂肪瘤(AML)的疑似TSC病例,检测错构瘤蛋白和结节蛋白的表达,以确定染色模式是否可以预测突变状态或肾局限性疾病的TSC可能性。这18例病例包括15例肾切除术和6例TSC相关肾细胞癌(RCC)的1个切片。对照包括5例肿瘤肾切除术中的非肿瘤性肾脏、4例散发性AML病例和6例透明细胞RCC。在14例TSC病例中,9例有AML,9例有RCC,5例有多囊肾病,8例有由大嗜酸性细胞衬里的嗜酸性囊肿(EC)。对照和研究病例显示,近端小管(PT)有管腔染色,远端小管/集合管有外周膜染色,错构瘤蛋白呈阳性,结节蛋白呈细胞质染色。嗜酸性囊肿在错构瘤蛋白染色中呈PT样管腔染色,结节蛋白呈细胞质反应。错构瘤蛋白在所有AML的肌样细胞中染色。除1例上皮样AML外,所有AML中的结节蛋白均为阴性。除1例RCC外,所有RCC的结节蛋白均为阳性;13例RCC(7例TSC/6例非TSC)的错构瘤蛋白为阴性,4例呈弱阳性反应。我们得出结论,TSC的EC来源于近端小管。AML和大多数RCC的错构瘤蛋白和结节蛋白染色模式相反,无法预测TSC中的突变,也无法预测多灶性AML患者是否患有TSC。